fda approval tirzepatide Grants a New Indication for Obesity Management The US-FDA has approved Tirzepatide
Description
In addition, these medications may increase the risk of gallbladder disease, acute kidney injury, and allergic reactions
A key paper published by Unger and Orci in 1975 helped to intensify research into the molecule (Unger, Orci)
doi: 10.2337/db14-0302 44
They are protected by a portfolio of overlapping patents covering different aspects of the product, each with its own expiration date
